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Abstract
The objectives of this study were to isolate and identify the actinomycetes strains from the soil 
and marine sediments and to evaluate the antimicrobial, antioxidant and cytotoxic activity of 
their bioactive secondary metabolites. Eight actinomycetes strains were isolated from soil and 
marine sediment samples collected from different areas in Egypt. Only three actinomycetes 
exhibited a wide spectrum of antimicrobial activities. They were active in vitro against microbial 
pathogen viz: Staphylococcus aureus, Escherichia coli, Salmonella typhi, Aspergillus parasiticus, 
Fusarium solani and Fusarium oxysporum. These promising isolates were selected and identified 
using molecular identification technique and identified as Streptomyces spp. The crude extracts 
from the three Streptomyces exhibited potent antimicrobial activities against a set of microbial 
pathogens as well as antioxidant and anticancer activity in human hepatocellular carcinoma 
cell line (HepG2). The crude extract of Streptomyces isolate D showed antitumor activity with 
lC50 0.85 µg/ mL. Forty compounds were identified from the two most promising ethyl acetate 
extracts of culture broth of Streptomyces sp. (D-EGY) by Gas Chromatography-Mass Spectrometry 
analysis. It could be concluded that the streptomycetes isolated from the Egyptian environment 
are promising candidates as antimicrobial, antioxidant and anticancer.
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Introduction
Moulds represent a great challenge 
confronting food and feed industry all over the 
world. The moulds cause great losses worldwide 
in food and feed supplementation due to the 
production of mycotoxins (Cheong et al., 2014). 
Contamination of foods by pathogenic bacteria 
(such as Salmonella typhimurium, Escherichia coli, 
Campylobacter jejuni, Legionella pneumophila, 
Staphylococcus aureus, etc.) results in numerous 
foodborne diseases (Targowski & Płusa, 2015). 
Infectious diseases account for nearly 40% of 
the total 50 million annual estimated deaths 
worldwide, whereas in many developing 
countries microbial diseases constitute the major 
cause of death (Abdalhai et al., 2015).
 In order to achieve improved food safety 
against such pathogens, several traditional 
means for the control of microbial spoilage 
and safety hazards in foods are being replaced 
by combinations of innovative technologies 
including the biological antimicrobial systems. 
Antimicrobial resistance among pathogenic 
microorganisms has led to a renewed search for 
new antimicrobial agents from microorganism 
such as actinomycetes. 
 Actinomycetes are Gram-positive, free-
living, spore forming, saprophytic, filamentous 
bacteria, extensively dispersed in water, soil 
which has an ecological significant in soil nutrient 
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cycling for colonizing plants and have DNA with 
high GC content (69-73%). Of all the genera of 
the actinomycetes, Streptomyces is the largest 
number of species and varieties occurred 
in nature and they are playing an extensive 
role in the pharmaceutical as well as medical 
industry for their capacity to produce secondary 
metabolites (Janardhan et al., 2014). 
Over 10,000 bioactive secondary 
metabolites are produced by actinomycetes, 
representing 45% of all bioactive microbial 
metabolites discovered. Many of these bioactive 
compounds were isolated and characterized and 
have been developed into drugs for treatment 
of wide range of diseases in human, animals and 
the agriculture sectors (Subathra et al., 2013). 
Actinomycetes are the most prolific producers 
of antibiotics accounting for about 80% of the 
known antibiotics (Subramani & Aalbersberg, 
2012). Novel secondary metabolites with a wide 
range of biological activities may ultimately 
find applications as anti-infective, anticancer, 
antibacterial, antifungal, antiviral, anti-parasitic, 
immunosuppressive, enzyme inhibitory and 
diabetogenic (Kekuda et al., 2010). To cope up 
with the demand for these new pharmaceutical 
and agriculture compounds, researchers 
are looking for novel microorganisms in new 
environments. Therefore, the aim of the current 
research was to isolate and characterize new 
Egyptian soil and marine actinomycetes strains. 
The isolates were further screened for bioactive 
potential secondary metabolites to evaluate 
their ability as antimicrobial, antioxidant and 
cytotoxic activity.
 
Material and methods
 Microorganisms 
Gram+ve bacteria (Staphylococcus 
aureus), Gram-ve bacteria (Escherichia coli, 
Pseudomonas aeruginosa, and Salmonella 
typhi), yeast (Candida albicans) as well as fungi 
(Aspergillus niger and Aspergillus parasiticus) 
were obtained from the culture collection of the 
Microbial Resources Centre (MlRCEN), Faculty of 
Agriculture, Ain Shams University, Cairo, Egypt. 
Fusarium solani, and Fusarium oxysporum were 
isolated from maize samples in Egypt.
Sample collection
Soil samples were collected from 
agricultural soil surrounding Mansoura city, 
Dakahlia governorate (coordinates are latitude 
31° N and longitude 31° E), Egypt during April, 
2015. The samples were taken at 10 cm depth 
using sterile spatula and each sample was 
placed in sterile plastic bags and transferred 
to the microbiology laboratory at Microbial 
Chemistry Department, National Research 
Centre, Dokki, Cairo, Egypt. The samples were 
sieved and air dried for 3-5 days at 25°C then 
was kept at 10°C in an incubator until used for 
the isolation of actinomycetes. Marine sediments 
samples were collected from Ras Sedr city, Suez 
Gulf, South Sinai governorate (coordinates are 
latitude 29° N and longitude 32° E), Egypt during 
May, 2015 under aseptic conditions using a piston 
core sediment sampler at a depth of 4-5 cm and 
stored at 4°C in Microbial Chemistry Laboratory, 
National Research Centre.  
Isolation of actinomycetes
Dried soil samples (50g) were suspended 
separately in 200 mL of sterile distilled water 
and shaken on a reciprocal shaker for 2 h. The 
isolation of actinomycetes was carried out 
using starch-nitrate agar (SNA) consisting of 20 
g/L starch, 1 g/L KNO3, 0.5 g/L K2HPO4, 0.5 g/L 
MgSO4.7H2O, 0.5 g/L NaCl, 0.01 g/L FeSO4, 15 
g/L agar and supplemented with nystatin at a 
concentration of 50 µg/mL as an antifungal and 
nalidixic acid at a concentration of 20 µg/mL 
as an antibacterial (Sineva & Terekhova, 2015). 
However, marine sediments (1g) were suspended 
in 100 mL of 0.8% sterile saline solution and 
agitated for 30 min using orbital shaker incubator 
(100 rpm) at 30°C. The isolation of actinomycetes 
from marine sediments was carried out using 
starch-casein agar (SCA) consisting of 10 g/L 
soluble starch, 2 g/L K2HPO4, 2 g/L KNO3, 0.3 g/L 
casein, 0.05 g/L MgSO4·7H2O, 0.02 g/L CaCO3, 
0.01 g/L FeSO4·7H2O, 15 g/L agar and 1000 mL 
filtered sea water supplemented with 25 µg/mL 
cyclohexamide and 10 µg/mL nalidixic acid to 
minimize contamination with fungi and bacteria, 
respectively. The shaken suspensions for soil or 
marine samples were diluted using serial dilution 
procedure (10-1 to 10-6) and aliquots (100 µL) from 
the different dilutions were used to inoculate the 
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medium plates. The plates were incubated at 
30°C for two weeks. The growing colonies were 
sub-cultured and transferred to slants without the 
antibiotic substance and kept at 4°C until use. 
These actinomycetes strains were maintained on 
SNA and SCA medium and incubated for 14 days 
in an incubator in the dark at 28°C. The micro-
morphology and sporulation were observed by 
optics microscopy (Olympus, Japan).
 Antagonistic activity of actinomycetes isolates
The plate diffusion method was used 
for the antagonistic assay of the actinomycetes 
isolates. In brief, the isolates were removed 
from their agar using a sterile cork bore (5 mm 
in diameter) and placed onto agar plate lawn 
with the pathogenic fungi or bacteria e.g. A. 
parasiticus, F. Solani, F. oysporum, E. coli, S. 
typhi and S. aureus and incubated at 37°C for 
24 h for bacteria and 28°C for 5 days for fungi. 
The formation of halo zone was considered as 
positive reaction. The diameter of the growth 
inhibition zones were measured averaged and 
the mean values were recorded.
Molecular identification of actinomycetes 
isolates
The three actinomycetes isolates 
(showed the highest antagonistic activity against 
the tested pathogenic fungi and bacteria) were 
identified according to a molecular biological 
protocol by DNA isolation, amplification (PCR) 
and sequencing of the ITS region. The forward 
primers 27F (5’-AGAGTTTGATCMTGGCTCAG-3’), 
and 518F (5’-CCAGCAGCCGCGGTAATACG-3’) 
and reverse 1492R 
(5’-TACGGYTACCTTGTTACGACTT-3’), and 800R 
(5’-TACCAGGGTATCTAATCC-3’) were used. The 
purification of the PCR products was carried out 
to remove unincorporated PCR primers and dNTPs 
from PCR products by using Montage PCR Clean 
up kit (Millipore). Sequencing was performed 
using Big Dye terminator cycle sequencing kit 
(Applied BioSystems, USA). Sequencing products 
were resolved on an Applied Biosystems model 
3730XL automated DNA sequencing system 
(Applied BioSystems, USA). Amplification and 
sequencing of the 16S rRNA gene had been 
done according to Myer et al. (2016). Blast 
program was used to assess the DNA similarities 
(www.ncbi.nlm.nih.gov/blst).   
 Preparation of Streptomyces species extracts 
The identified Streptomyces species were 
cultivated on starch nitrate agar plate medium 
at 28°C for 7-14 days (until complete sporulation). 
One-litre Erlenmeyer flasks, each containing 250 
mL of ISP2 medium consisting of 4 g/L glucose, 4 
g/L yeast extract, and 10 g/L malt extract, were 
inoculated with spore suspension from well grown 
slants (only one slant was used to inoculate two 
flasks). The flasks were incubated at 30°C using 
rotary shaker (150 rpm) or static in self incubator 
at the same temperature for 15 days. The cells 
were separated by centrifugation at 5000 rpm 
and 4°C, and both the cell-free supernatant and 
the cells biomasses were subject to extraction. 
The supernatants were extracted with ethyl 
acetate 3 times. However, the cell biomasses 
were extracted with acetone then the acetone 
evaporated under vacuum and the remaining 
water residue was re-extracted 3 times with 
acetyl acetate (Shaaban et al., 2013). The 
yielded extracts form the cell-free supernatant 
or the cells biomasses of the three Streptomyces 
species using different routes are presented in 
Table 1. 
Antimicrobial activity
The antimicrobial activities of crude 
extracts of the isolated Streptomyces spp. 
were tested against S. aureus, C. albicans, F. 
oxysporum, P. aeruginasa and A. niger. The 
obtained extracts were dissolved in methanol 
and filter paper discs (5 mm diameter, Whatman 
No.1) were saturated with 10 µL  from the water or 
the methanol extract, and dried for 1 h at room 
temperature under sterilized conditions (final 
extract concentration was 100 µg per disc). The 
paper discs were placed on inoculated agar 
plates with the tested microbes and incubated at 
the appropriate temperature and time for each 
microorganism. Bacterial strains were grown on 
nutrient agar; yeast strains were grown Potato 
dextrose agar (PDA) medium (DSMZ GmbH, 
Germany), and the fungal strain was grown on 
Czapek-Dox medium (DSMZ GmbH, Germany). 
After the incubation period, the diameter of the 
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growth inhibition zones were measured averaged 
and the mean values were recorded. Neomycin 
and cycloheximide at a concentration of 50 µg/
disc were used as antibacterial and antifungal 
control agents, respectively.
Table 1.Crude extracts of Streptomyces sp. and extraction conditions
Streptomyces sp. Extract number Extraction conditions
5S2-EGY
I Extracted from supernatant incubated under rotary shaking
II Extracted from cells incubated under rotary shaking
III Extracted from supernatant incubated under static
IV Extracted from cells incubated under static
D- EGY
V Extracted from supernatant incubated under rotary shaking
VI Extracted from cells incubated under rotary shaking
VII Extracted from supernatant incubated under static
VIII Extracted from cells incubated under static
5S1-EGY
IX Extracted from supernatant incubated under rotary shaking
X Extracted from cells incubated under rotary shaking
XI Extracted from supernatant incubated under static
XII Extracted from cells incubated under static
Antioxidant activity (DPPH scavenging assay)
The crude extracts of the bioactive 
secondary metabolites showing high antimicrobial 
activity were studied for their antioxidant activity. 
One hundred µL of the extracts at concentrations 
of 5, 7.5 and 10 mg/mL were added to 5 mL of 
the 2,2-Diphenyl-1-Picrylhydrazyl (DPPH) solution 
(0.005% in methanol). After 30 min incubation 
at room temperature, the absorbance was 
read against pure methanol at 520 nm. The 
radical-scavenging activities of the samples 
were calculated as percentages of inhibition 
according to the following equation:
Where: A blank is the absorbance of the 
control (containing all reagents except the test 
compound), and A sample is the absorbance 
of the test compound. All tests were done in 
triplicate. 
Cytotoxic activity
Hepatocellular Carcinoma Cell Line (HepG2)
Potential cytotoxicity of actinomycetes 
secondary metabolites crude extracts was 
performed. Briefly, human hepatocellular 
carcinoma cell line (HepG2) (1x104 cells/well), 
obtained from the National Cancer Institute, 
Cairo University, Cairo, Egypt, were seeded 
in 96-microwell plate and allowed to grow 
overnight before the treatment with the crude 
extracts of actinomycetes to allow attachment 
of the cell to the wall of the plate. Different 
concentrations of the crude extracts (0.39 - 50 
µg/mL) were added to the cells monolayer and 
triplicate wells were prepared for each individual 
extract. Monolayer cells were incubated with 
the extract in humidified incubator with 5% CO2 
at 37°C and after 48 h; cells were fixed by the 
addition of 25 μL of cold 50% trichloroacetic 
acid (TCA). After incubation for one hour at 
4°C, the plate was washed five times with tap 
water to remove TCA, medium and dead cells 
then the plate was dried in air.  Fifty μL of 0.4% 
sulforhodamine B stain dissolved in 1% acetic acid 
was added to each well and allowed to stand for 
30 min. The plate was subsequently washed four 
times with 1% acetic acid to remove excess stain 
then dried in air again. One hundred and 50 μL 
of 10 mM aqueous Tris-Base [tris(hydroxylmethyl) 
aminomethane] was added to solubilize the cell-
bound dye. The plate was then shaken for 10 min 
followed by the reading of optical density (OD) 
at 570 nm in a microplate spectrophotometer.
Identification of chemical composition of the 
crude extracts of using GC-MS 
The most promising two crude extracts 
(V and VII) that showed high antimicrobial and 
cytotoxic activities were analysed by a coupled 
Varian gas chromatography/ mass spectrometry 
(Perkin Elmer Auto XL GC, Waltham, MA, USA) 
equipped with a flame ionization detector to 
identify their chemical composition. The GC 
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conditions were EQUITY-5 column (60 m x 0.32 mm 
x 0.25 μm); H2 carrier gas; column head pressure 10 
psi, the oven temperature was maintained initially 
at 70°C for 2 min, and then programmed from 
70 to 250°C at a rate of 3°C/min. The ionization 
voltage was 70 eV, mass range m/z 39-400 amu. 
The identification of individual compounds was 
based on their retention times relative to those of 
authentic samples and matching spectral peaks 
available with the published data.
Statistical analysis
All data were statistically analyzed by 
analysis of Variance (ANOVA). The significance 
of the differences among treatment groups was 
determined by Waller-Duncan k-ratio (Waller 
& Duncan, 1969). All statements of significance 
were based on probability of P ≤ 0.05.
Results
Isolation of actinomycetes
Four actinomycetes species were 
isolated from soil samples and nomeados S14, 
AM2, S3 and L. Other 4 species were isolated 
from marine sediments samples and nomeados 
5S1, 5S2, D and 25. It is of interest to mention that 
the genus Streptomyces was the dominant in all 
species in the marine sediments samples. 
Antagonistic activity of the isolated 
actinomycetes  
The results of antagonistic activity of 
the isolated actinomycetes presented in Table 
2 revealed that only three isolates e.g. 5S1, 5S2 
and D showed the highest antagonistic activity 
against most of the tested microorganisms. Two 
isolates e.g. AM2 and L showed only antagonistic 
activity against the tested fungi but not against 
bacteria and only one isolate (S3) did not show 
any antifungal or antibacterial activity (Table 
2). Consequently, the three actinomycetes 
isolates that showed strong antimicrobial activity 
(5S1, 5S2 and D) were subjected to molecular 
identification technique.
Molecular Identification of the actinomycetes 
isolates 5S1, 5S2 and D 
Table 2. Antimicrobial activity of actinomycetes species
Actinomycetes 
Isolates
Inhibition zone (mm)
A. parasiticus F. solani F. oysporum E. coli S. typhi S. aureus
5S1 25.0 ± 0.0 30.0 ± 0.0 20.5 ± 0.05 10.5 ± 0.05 ND 10.5 ± 0.05
5S2 27.0 ± 5.0 26.5 ± 1.5 19.0 ± 0.0 10.0 ± 0.05 ND 10.0 ± 0.05
D 25.0 ± 5.0 30.0 ± 0.0 23.0 ± 2.0 12.0 ± 1.0 14 ± 0.0 12.0 ± 1.0
S14 10.0 ± 10 22.5 ± 2.5 20.0 ± 0.0 ND ND ND
AM2 15.0 ± 0.0 30.0 ± 5.0 ND ND ND ND
L ND 13.5 ± 0.05 14.0 ± 1.0 ND ND ND
S3 ND ND ND ND ND ND
25 13.5 ± 0.05 ND ND ND ND ND
Results are mean ± SEM. ND: Non detected
The molecular identification of the three 
actinomycetes revealed that a nucleotide 
sequence of 967, 971 and 1054 bp of the whole 
16S rRNA gene of the Streptomyces sp. for isolate 
5S1, 5S2 and D, respectively was determined 
in both strands. BLAST search revealed that 
99% similarity to Streptomyces sp. and the 
phylogenetic trees of these Streptomyces 
were also constructed (Figure 1a-c). The gene 
sequences of actinomycetes were deposited 
in GenBank database; as Streptomyces sp. 5S1-
EGY (Accession No. KP336669.1), Streptomyces 
sp. 5S2-EGY (Accession No.  KP336670.1), 
and Streptomyces sp. D-EGY (Accession No. 
KP336671.1). It is well known that the traditional 
identification techniques are depending on 
the culture morphology and some biochemical 
reactions are known to be a time consuming 
methods that also need a talented persons 
with very high experience (Sugita & Nishikawa, 
2003). Consequently, the use of DNA sequences 
in the current study was proved to be an 
objective, reproducible, accurate and quick 
tools for identification. Universal primers: 
27F (5'GAGTTTGATCATGGCTCAG3'), 1492R 
(5'GGTTACCTTGTTACGACTT3') [for PCR] and 
518F (5’CCAGCAGCCGCGGTAATACG3’) and 
800R (5’TACCAGGGTATCTAATCC3’) were used 
in the study of the genotypic identification of 
microorganisms isolated from non-parenteral 
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Figure 1. Phylogenetic tree showing relationship of strain 5S1 (a), 5S2 (b) and D(c), and the type 
strains of closely related Streptomyces species constructed using the neighbour-joining method 
and based on 16S rRNA gene sequences.
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pharmaceutical formulations. Moreover, 
the primers 27F and 1492R were used for the 
identification of bacteria.
Antimicrobial activity of crude extract of 
Streptomyces sp 
The crude extracts of the three isolates 
5S1, 5S2 and D were used to investigate the 
antimicrobial activity against pathogenic 
microorganisms. The results revealed that the 
extracts of these isolates inhibited the growth of 
pathogenic microorganisms at varying degrees 
(Figure 2).
Figure 2. Antimicrobial activity of actinomycetes crude extracts. Results are mean ± SEM. Methanol 
and water, used as controls showed no zone inhibition
3. The degree of stable DPPH* decolourization to 
DPPHH yellow (reduced form of DPPH) indicated 
the scavenging efficiency of the extract. The 
recorded values of radical scavenging ability 
of different extracts I, III, V, VI, VII, and VIII at a 
concentration of 10 mg/mL were  82.06, 46.71, 
20.52, 14.74, 18.74, and 11.01 % respectively. 
Cytotoxic activity
Human hepatocellular carcinoma cell 
lines (HepG2) was used as a model system to 
examine the cytotoxic effect of the isolated 
Streptomyces crude extracts at a concentration 
varied from 0.39 to 50 µg. The concentration of 
the crude extracts leading to 50% of cytotoxicity 
was then determined. The results presented in 
Figure 4 showed that the ethyl acetate extract of 
the isolate D caused an inhibitory activity against 
HepG2 cell lines with IC50 = 0.85 µg. The results 
presented in Figure 5 and the regression analysis 
presented in Figure 6 also showed the effects of 
these extracts on HepG2 cell line viability.
Identification of chemical composition by GC-MS 
Based on the above mention results, the 
crude extract of static and of shaken culture 
supernatant of Streptomyces isolate D showed 
The extract isolated from the two 
actinomycetes strains (D, and 5S2) inhibited the 
growth of nearly all the tested microorganisms, 
whereas the third actinomycetes extract (5S1) did 
not show any inhibition of the tested organisms. 
These extracts showed antimicrobial activities 
against the two tested bacteria and Candida 
albicans. Neomycin as anti bacterial standard 
exhibited the following results: S. aureus (18 mm), 
P. aeruginosa (21 mm), C. albicans (23 mm) and A. 
niger (0 mm). On the other hand Cyclohexamide 
as antifungal standard exhibited the following 
results: S. aureus (0 mm), P. aeruginosa (0 mm), C. 
albicans (0 mm) and A. niger (26 mm). Negative 
controls (discs with water and methanol) did not 
exhibit any antimicrobial activity against any the 
tested microorganisms.
Antioxidant activity
The crude extracts showing high 
antimicrobial activity (i.e. extracts I, III, V, VI, VII, 
and VIII) were evaluated for their antioxidant 
activity. The results DPPH free radical scavenging 
activity (%) of different ethyl acetate extracts of 
both Streptomyces species are shown in Figure 
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Figure 5. Effects of secondary metabolites extracted from Streptomyces sp. on HepG2 cell line viability
Figure 3. Antioxidant activity of actinomycetes crude extracts measured by DPPH assay. 
Results are mean ± SEM
Figure 4. Evaluation of cytotoxicity (IC50) against hepatocellular carcinoma. Results 
are mean ± SEM
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Figure 6. The regression analysis for the effect of secondary metabolites extracted from Streptomyces sp. on HepG2 cell line 
viability
the highest antimicrobial, antioxidant and 
cytotoxic effects. Consequently, these extracts 
were subjected to the identification of their 
active components. The chemical analysis of 
these crude extracts indicated the identification 
of 40 components for each extract, representing 
98.84% and 99.98% respectively (Tables 4 and 5). 
The major components in the extract of rotary 
shaker of the culture supernatant of D isolate 
(extract V) were, Butane, 2, 3-bis (trimethylsiloxy) 
(14.89%), 3-Trifluoromethylsulfonyl-4,5-dihydro-
2H-furan (11.37%), Allyl mercaptan (11.21%), 
2,3-Butanediol, O-(trimethylsilyl)-, monoacetate 
(10.66%), Butanoic acid, trimethylsilyl ester 
(9.83%),  Bis(2-ethylhexyl) phthalate (8.59%) and 
Ethanedioic acid, bis (trimethylsilyl) ester ( 8.22%) 
with the retention time  7.80, 6.41, 5.45, 11.15, 
10.60, and 62.97, respectively (Table 4). On the 
other hand, the major components in extract 
of the static culture supernatant of the same 
isolate (extract VII) were 1, 2-Dimethyl-2-pyrrolino 
[3, 2-c] pyridine (19.08%), 3-(4Vinyl benzyloxy) 
benzyl alcohol (18.37%), 3-Octanol-3, 6-dimethyl 
(12.66%) and 1, 2-Benzene dicarboxylic acid, 
diisooctyl ester (7.38%) with the retention time 
7.86, 7.80, 26.48 and 62.94, respectively (Table 5).
Discussion 
Streptomyces are the largest antibiotic-
producing genus has antifungal, antibacterial, 
antiparasitic drugs and also a wide range 
of other bioactive compounds such as 
immunosuppressants. However, isolation of 
actinomycetes has always been faced with the 
difficulties in comparison to their competitors such 
as other bacteria and fungi which may be due to 
their long incubation period. The actinomycetes 
isolation ratio was increased by pre-treatment 
of the samples by subjecting them to dry air for 
three weeks.
In the current study, the isolated 
actinomycetes showed high antagonistic 
activity against several pathogenic fungi and 
bacteria. Patel et al. (2014) reported that 79% of 
the actinomycetes isolates were active against 
at least one of the 18 tested pathogens. Other 
reports indicated that actinomycetes isolates 
showed inhibitory activity against mycelial 
growth of plant pathogenic fungi like Alternaria 
mali, Colletotrichum gloeosporides, F. oxysporum 
(Lim et al., 2000); against yeasts and  gram 
positive and gram negative antibiotic resistant 
pathogens (Thirumalairaj et al., 2015). 
The three actinomycetes isolates that 
showed the highest antagonistic effect against 
the tested microorganisms (i.e 5S1, 5S2 and D) 
were identified as Streptomyces spp. by using 16S 
rRNA molecular technique. 
The crude extract of the bioactive 
compounds isolated from the three isolates of 
Streptomyces showed antimicrobial activity 
against different microorganisms. Similar results 
were reported by Khamna et al. (2009) who found 
that the crude extract was active as antifungal 
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Table 4. Chemical compositions of the ethyl acetate extract (V) of the filtrate of shaken culture broth of Streptomyces 
sp. D-EGY.
No. RT Area % M.W M.F. Compound name
1 5.02 0.73 132 C6H16OSi Silane, trimethylpropoxy
2 5.33 3.97 990 C60H78S6
1,4-Bis(3,3",4,4"-tetra butyl-2,2':5',2''-terthie n-2-yl)-1,3-
butadiyne
3 5.45 11.21 74 C3H6S Allyl mercaptan
4 6.15 0.85 162 C6H18OSi2 Dimethyl(trimethylsilyl) methoxy silane
5 6.41 11.37 202 C5H5F3O3S 3-Trifluoromethylsulfonyl-4,5-dihydro-2H-furan
6 6.71 8.22 234 C8H18O4Si2 Ethanedioic acid, bis(trimethylsilyl) ester
7 7.04 0.12 148 C7H8N4 s-Triazolo[4,3-a]pyrazine, 3-ethyl
8 7.13 0.28 130 C7H14O2 (S)-6-Hydroxyheptanoic acid 1, 2
9 7.19 0.24 131 C6H10ClN 5-Chloro-1,4-dimethyl -2,3-dihydro-1H-pyrrole
10 7.41 0.52 320 C20H20N2O2 Bis[2-(1-methylethenyl)anilide]
11 7.51 0.99 172 C11H12N2  4-(1-Aminobut-3-enyl )benzonitrile
12 7.57 0.68 323 C19H33NO3 Phenol, 2,6-di(tert-butyl)-4-bis (2-hydroxyethyl)amin
13 7.80 14.89 234 C10H26O2Si2 Butane, 2,3-bis(trimethylsiloxy )
14 8.13 0.35 413 C19H39NO3Si3 
Silanamine, N-[2-[3-methoxy-4-[(trimethylsilyl)oxy]phenyl]-
N,1,1,1-tetramethyl-2-[(trimethylsilyl)oxy]ethyl]-
15 8.40 3.13 2084 NA Sscfggridrigaq Sglggns/3
16 9.84 1.20 2027 NA Cnckapetascarr Cqqh/2
17 10.60 9.83 160 C7H16O2Si 7 Butanoic acid, trimethylsilyl ester
18 11.15 10.66 204 C9H20O3Si 2,3-Butanediol, O-(trimethylsilyl)-, monoacetate1
19 13.85 0.61 471 C21H45NO3Si4 Epinephrine-Tetratms 
20 13.97 0.30 415 C27H45NO2 6á-Nitrocholest-4-ene
21 14.09 0.83 266 C15H26O2Si 1-Methoxy5-trimethylsilyloxy-3-phenylpentane
22 14.22 0.21 280 C16H28O2Si 1-Methoxy-5-dimethyl (ethyl)silyloxy-3-phenylpentane
23 14.30 0.23 200 C11H24OSi Butyl(dimethyl)silyloxy cyclopentane
24 14.63 0.60 202 C9H18O3Si Pantoyl lactone, trimethyl silyl
25 16.54 0.18 326 C15H28B2O6 
à-D-Mannopyranoside, methyl, cyclic 
2,3:4,6-bis(butylboronate)
26 19.77 0.41 306 C13H30O4Si2 2-Mono-isobutyrin, bis(trimethylsilyl)
27 22.36 0.27 314 C17H38OSi2 11-(Trimethylsilylmethyl)dimethylsilyloxy-1 -undecene
28 23.86 0.44 358 C21H18N4O2
1-Amino-2-cyano-3,4-d ihydro-4-ethoxycarbo nyl-3-
phenylpyrido[1, 2-a] benzimidazole1
29 26.29 0.82 274 C11H23BO5Si 
à-L-Galactopyranoside , methyl 6-deoxy-2-O-
(trimethylsilyl)-, cyclic methylboronate
30 40.53 0.21 256 C16H32O2 Tetradecanoic acid, 12-methyl-, methyl ester
31 43.27 0.80 284 C18H36O2 i-Propyl 12-methyltetradecanoate
32 44.94 0.51 270 C17H34O2 Pentadecanoic acid, 14-methyl-, methyl ester
33 46.96 0.47 210 C11H18N2O2 1,4-diaza-2,5-dioxo-3isobutyl bicyclo[4.3.0]nonane
34 47.45 0.43 330 C19H38O4 Hexadecanoic acid, 2,3-dihydroxypropyl ester
35 47.97 2.47 234 C17H30 3-Methylene-9-pentyl piro[5.5]undecane
36 50.24 0.83 294 C19H34O2 9,12-Octadecadienoic acid, methyl ester, (E,E)
37 50.39 0.18 296 C19H36O2 16-Octadecenoic acid, methyl ester
38 52.19 0.62 308 C20H36O2 Linoleic acid ethyl ester
39 52.35 0.72 308 C20H36O2 Linoleic acid ethyl ester
40 62.97 8.59 390 C24H38O4 Bis(2-ethylhexyl) phthalate
M.F.: Molecular formula; M.W.: Molecular weight; RT: Retention time
1Anticancer; 2Antioxidant (Data obtained from Dr. Duke’s Phytochemical and Ethnobotanical databases)
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Table 5. Chemical compositions of the ethyl acetate extract (VII) of the filtrate of static culture broth of Streptomyces 
sp. D-EGY.
No. RT Area % M.W M.F. Compound name
1 5.02 1.67 158 C6H10F4 Hexane, 3,3,4,4-tetrafluoro
2 5.18 7.85 2904 NA unknown
3 5.98 0.29 72 C4H8O Butanal
4 6.07 0.44 383 C18H37NO2Si3
1-(4'-trimethysilyl oxy phenyl)-1-trimethylsilylox y-2-
methyltrime thylsilyl-amino ethane
5 7.80 18.37 240 C16H16O2 3-(4Vinylbenzyloxy) benzyl alcohol
6 7.86 19.08 148 C9H12N2 1,2-Dimethyl-2-pyrrolino[3,2-c]pyridine1
7 9.98 0.39 192 C11H12O3 3-Isopropoxyphthalid
8 11.25 0.51 2084 NA unknown
9 13.36 0.90 282 C19H38O 2-Nonadecanone
10 14.07 2.32 385 C22H27NO5 cis-1,2,7,9,10-pentamethoxy aporphine
11 15.02 0.63 990 C60H78S6
1,4-Bis(3,3",4,4"-tetra butyl-2,2':5',2''-terthien-2-yl)-1,3-
butadiyne
12 20.52 0.57 122 C7H6O2 Benzoic acid
13 22.11 1.83 114 C6H14N2 N,N'-Dimethyl piperazine
14 22.84 0.80 340 C20H24N2O3
 (+-)-5-Oxo-2a,7-.alph a,19,20-tetrahydro-16 
epipleiocarpamine
15 23.13 0.83 257 C14H27NO3 12-Dimethylamino-10oxododecanoic acid
16 23.86 0.51 339 C15H21N3O4S
Ethyl 2-[3'-(3''-methyl-1"-hydroxycarbonylbutyl) 
thioureido)pyridine-3-carboxylate
17 24.24 3.42 216 C12H24O3
Propanoic acid, 2-methyl-, 2-ethyl-3-hydroxyhexyl 
ester
18 26.48 12.66 158 C10H22O 3-Octanol-3,6-dimethyl
19 39.05 0.67 242 C15H30O2 Pentadecanoic acid
20 40.54 0.60 256 C16H32O2 Tetradecanoic acid-12-methyl, methyl ester
21 43.70 0.74 270 C17H32O2 Pentadecanoic acid, 14-methyl-, methyl ester
22 43.78 0.36 242 C13H26O2Si
(S)-5,5-Dimethyl-4-((tert-butyldimethylsilyl)oxy)-2-
cyclopentenol 1, 2
23 44.13 2.42 242 C13H26O2Si
 (S)-5,5-Dimethyl-4-((tert-butyldimethylsilyl)oxy)-2-
cyclopentenol 1, 2
24 44.97 0.87 270 C17H34O2 Hexadecanoic acid, methyl ester
25 46.15 0.75 873 C41H47NO20 Wilfortrine
26 46.24 1.54 447 C16H19N2O9S2 Glucobrassicin
27 46.73 1.05 378 C27H54 Cyclohexane-1,3,5-trimethyl 2octadecyl
28 47.16 0.34 284 C18H36O2 Octadecanoic acid
29 47.28 0.63 284 C18H36O2 Hexadecanoic acid-14methyl,  methyl ester
30 47.54 2.00 210 C11H18N2O2
Pyrrolo[1,2-a]pyrazine -1,4-dione, hexahydro-3-(2-
methyl propyl)
31 47.80 1.59 256 C16H32O2 Hexadecanoic acid
32 48.01 0.32 170 C6H10N4S 2-Hydrazino-4-methyl6-methyl thiopyrimidine 1, 2
33 48.14 0.56 378 C27H54 Cyclohexane, 1,3,5-trimethyl-2-octadecyl
34 49.88 1.40 270 C17H34O2 Pentadecanoic acid, 14-methyl, methyl ester
35 50.24 0.32 294 C19H34O2 9,12-Octadecadienoic acid, methyl ester
36 52.23 0.55 308 C20H36O2 Ethyl-9-cis-11-trans-octadecadienoate
37 52.42 1.01 310 C20H38O2 9-Octadecenoic acid (Z)-, ethyl ester
38 53.04 0.34 586 C36H58O6
Hexadecanoic acid, 1a,2,5,5a,6,9,10,10a-
octahydro-5,5a-dihydroxy -4-(hydroxyl methyl)-1, 
2,3,22-Triacetoxystictane1
39 62.94 7.38 390 C24H38O4 1,2-Benzene dicarboxylic acid, diisooctyl ester
40 75.12 1.47 679 C35H52F3NO5Si2
(4S,5S-)4-(tert-Butyl dimethyl silyloxy methyl) 
-5-[(1R,4S,2E)-4-tert-b utyldiphenylsilyloxy-1(2,2,2-
trifluoroaceylamino)pent-2-enyl]-2,2-di methyl-1,3-
dioxolane 1, 2, *
M.F.: Molecular formula; M.W.: Molecular weight; RT: Retention time. 1Anticancer; 2Antioxidant (Data obtained from Dr. Duke’s Phytochemical 
and Ethnobotanical databases). *’Smart drugs’ enhance the processes associated with cognitive brain activity, allowing the user to experience 
positive benefits
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against R. tolonifera, A. flavus, F. oxysporum 
and Alternaria. Moreover, several Streptomyces 
was reported to produce antifungal secondary 
compounds and the antagonistic activity of 
Streptomyces and the fungal pathogens is related 
to these compounds such as chitinase, β-1,3- 
glucanase, chitosanase, and protease which 
was documented to have have the ability to lyse 
fungal cell walls and suppress fungal growth and 
both exponential and stationary culture filtrates 
of Streptomyces sp exhibited antifungal activity 
(Wang et al., 2011). 
In DPPH scavenging assay, the 
antioxidants reduced the purple coloured 
DPPH radical to a yellow coloured compound 
diphenylpicrylhydrazine and the extent of 
reaction depended on the hydrogen donating 
ability of the antioxidants. Although the 
scavenging abilities of the crude extract reported 
herein was lesser, it was evident that the extracts 
showed hydrogen donating ability and therefore 
could serve as free radical scavengers and acting 
possibly as primary antioxidants. According to 
Taylor et al. (2007), there is no satisfactory drug 
to control cancer which is known to be the 
leading cause of death in the world. The limited 
availability to control cancer drug resistance 
along with the emergence of new pathogens 
has led the expansion of the search for novel 
drug candidates. According to the criteria of the 
National Cancer Institute (NCI, USA), the crude 
extract is considered promising as an antitumor at 
IC50 of ≤ 30 µg/mL however; for a pure substance 
IC50 should be ≤ 4 µg/mL, which corresponds to 
strong cytotoxic activity (Dalal et al., 2016). The 
IC50 values of the crude extract of actinomycetes 
secondary metabolites in this study were found to 
be lower (18.4, 9.97, 0.85, 5.5, 4.21, and 4.91 µg/
mL for extracts I, III, V, VI, VII, and VIII, respectively) 
than that specified by the NCI for crude extracts, 
thus they are promising for further purification. 
Among the members of actinomycetes genus, 
Streptomyces sp. is a dynamic producer of 
functional, bio-effective metabolites with broad 
pharmaceutical range having antimicrobial, 
antihelminthic, antitumor and antiviral agents 
(Ravikumar et al., 2008). The current study 
revealed that both the rotary shaker and static 
crude extract of the Streptomyces D-EGY showed 
the highest antimicrobial, antioxidant and 
anticancer properties. In this concern, Subashini 
& Kannabiran (2014) indicated that secondary 
metabolites from actinomycetes, especially the 
genus Streptomyces, are considered one of the 
most important sources for novel anticancer 
agents. The results of the present study suggested 
that the potential cytotoxic activity of extract VII 
against HepG2 could be due to the bioactive 
compound 1, 2- benzene dicarboxylic acid and 
hexadecanoic acid which were identified as the 
main components of Streptomyces sp. D-EGY 
(Krishnan et al., 2014). The mechanism by which 
these bioactive compounds can induce their 
cytotoxicity was suggested by the interference 
with basic cellular functions such as cell cycle, 
apoptosis, inflammation, angiogenesis, invasion 
and metastasis (Abe et al., 1993). The GC-MS 
results also revealed that complex mixture of 
numerous compounds were discovered. These 
results were similar to those reported by Ashok et 
al. (2014) who analysed secondary metabolites of 
Streptomyces albus and identified 8 compounds 
included 1-Octanol 2,7dimethyl which exhibited 
anticancer properties. Moreover, Abd-Elnaby et 
al. (2016) analysed Streptomyces parvus crude 
extract by GC-MS and found among others 
benzoic acid.
Conclusion
Streptomyces isolated from soil and 
marine sediments samples present varying 
degrees of antagonism against different 
pathogenic microorganisms. The crude extract 
of the isolates 5S1, 5S2 and D present greater 
antimicrobial, antioxidant and anticancer 
activity. Among them, the D-EGY isolate is the 
most effective. The chemical composition of 
these extracts revealed that they contain 40 
chemical compounds two of them are well 
known as anticancer. 
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